Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome associated neonatal lethality in Erk3?/? mouse pups

Pediatric Research

Volumn 76, Issue 1, 2014, Pages 24-32

  Cuevas Guaman, Milenka ^a   Sbrana, Elena ^b   Shope, Cynthia ^c   Showalter, Lori ^c   Hu, Min ^c   Meloche, Sylvain ^d   Aagaard, Kjersti ^c  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLYCOGEN; MITOGEN ACTIVATED PROTEIN KINASE 6; SANDOZ; SURFACTANT PROTEIN B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FETUS LUNG MATURATION; FETUS LUNG MATURITY; GENE DELETION; IMMATURITY; INTUBATION; LETHALITY; LUNG ALVEOLUS CELL; LUNG DEVELOPMENT; MALE; MOUSE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN MORTALITY; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA SEQUENCE; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CORTICOTROPIN-RELEASING HORMONE; CROSS-OVER STUDIES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; GLUCOCORTICOIDS; LUNG; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 6; PREGNANCY; PREGNANCY, ANIMAL; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TIME FACTORS;

EID: 84902667381     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.54     Document Type: Article

References (39)

1. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-Activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153-83.
2. Coulombe P, Meloche S. Atypical mitogen-Activated protein kinases: structure, regulation and functions. Biochimica et Biophysica Acta 2007;8:7.
3. Turgeon B, Saba-El-Leil MK, Meloche S. Cloning and characterization of mouse extracellular-signal-regulated protein kinase 3 as a unique gene product of 100 kDa. Biochem J 2000;346:Pt 1:169-75.
4. Aberg E, Perander M, Johansen B, et al. Regulation of MAPK-Activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4. J Biol Chem 2006;281:35499-510.
5. Julien C, Coulombe P, Meloche S. Nuclear export of ERK3 by a CRM1- dependent mechanism regulates its inhibitory action on cell cycle progression. J Biol Chem 2003;278:42615-24.
6. Schumacher S, Laass K, Kant S, et al. Scaffolding by ERK3 regulates MK5 in development. EMBO J 2004;23:4770-9.
7. Klinger S, Turgeon B, Lévesque K, Wood GA, Aagaard-Tillery KM, Meloche S. Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality. Proc Natl Acad Sci USA 2009;106:16710-5.
8. Kling DE, Brandon KL, Sollinger CA, et al. Distribution of ERK1/2 and ERK3 during normal rat fetal lung development. Anat Embryol (Berl) 2006;211:139-53.
9. Hsia CC, Hyde DM, Ochs M, Weibel ER; ATS/ERS Joint Task Force on Quantitative Assessment of Lung Structure. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 2010;181:394-418.
10. Rasaiah VP, Malloy JL, Lewis JF, Veldhuizen RA. Early surfactant administration protects against lung dysfunction in a mouse model of ARDS. Am J Physiol Lung Cell Mol Physiol 2003;284:L783-90.
11. Iwasaki T, Tamura S, Kumasaka T, et al. Exacerbation of influenzavirus pneumonia by intranasal administration of surfactant in a mouse model. Arch Virol 1999;144:675-85.
12. Fukushi M, Yamashita M, Miyoshi-Akiyama T, Kubo S, Yamamoto K, Kudo K. Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus. PLoS One 2012;7:e42419.
13. Mikawa K, Nishina K, Takao Y, Obara H. Intratracheal application of recombinant surfactant protein-C surfactant to rabbits attenuates acute lung injury induced by intratracheal acidified infant formula. Anesth Analg 2004;98:1273-9
14. Yap KL. A method for intratracheal inoculation of mice. Lab Anim 1982;16:143-5.
15. Yu H, Zeidan YH, Wu BX, et al. Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Cell Mol Biol 2009;41:367-75.
16. Revelli DA, Boylan JA, Gherardini FC. A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis. Front Cell Infect Microbiol 2012;2:164.
17. Driscoll KE, Costa DL, Hatch G, et al. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci 2000;55:24-35.
18. Blanco O, Pérez-Gil J. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat respiratory distress syndrome: role of the different components in an efficient pulmonary surfactant. Eur J Pharmacol 2007;568:1-15.
19. Rdiger M, Tölle A, Meier W, Rstow B. Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. Am J Physiol Lung Cell Mol Physiol 2005;288:L379-83.
20. Kramer BW, Jobe AH, Ikegami M. Exogenous surfactant changes the phenotype of alveolar macrophages in mice. Am J Physiol Lung Cell Mol Physiol 2001;280:L689-94.
21. Salez L, Balloy V, van Rooijen N, et al. Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. J Immunol 2001;166:6376-82.
22. Starcher B, Williams I. A method for intratracheal instillation of endotoxin into the lungs of mice. Lab Anim 1989;23:234-40.
23. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 2001;32:76-91.
24. Grier DG, Halliday HL. Effects of glucocorticoids on fetal and neonatal lung development. Treat Respir Med 2004;3:295-306.
25. Jobe AH. Glucocorticoids, inflammation and the perinatal lung. Semin Neonatol 2001;6:331-42.
26. Ridsdale R, Post M. Surfactant lipid synthesis and lamellar body formation in glycogen-laden type II cells. Am J Physiol Lung Cell Mol Physiol 2004;287:L743-51.
27. Muglia LJ, Jenkins NA, Gilbert DJ, Copeland NG, Majzoub JA. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J Clin Invest 1994;93:2066-72.
28. Muglia L, Jacobson L, Dikkes P, Majzoub JA. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995;373:427-32.
29. Petraglia F, Imperatore A, Challis JR. Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev 2010;31:783-816.
30. Reis FM, Fadalti M, Florio P, Petraglia F. Putative role of placental corticotropin- releasing factor in the mechanisms of human parturition. J Soc Gynecol Investig 1999;6:109-19.
31. Smith R, Nicholson RC. Corticotrophin releasing hormone and the timing of birth. Front Biosci 2007;12:912-8.
32. McLean M, Smith R. Corticotrophin-releasing hormone and human parturition. Reproduction 2001;121:493-501.
33. Smith R. Alterations in the hypothalamic pituitary adrenal axis during pregnancy and the placental clock that determines the length of parturition. J Reprod Immunol 1998;39:215-20.
34. Siler-Khodr TM, Forthman G, Khodr C, Matyszczyk S, Khodr Z, Khodr G. Maternal serum corticotropin-releasing hormone at midgestation in Hispanic and white women. Obstet Gynecol 2003;101:557-64.
35. Laatikainen TJ, Räisänen IJ, Salminen KR. Corticotropin- releasing hormone in amniotic fluid during gestation and labor and in relation to fetal lung maturation. Am J Obstet Gynecol 1988;159:891-5.
36. Weibel ER, Hsia CC, Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol (1985) 2007;102:459-67.
37. Brusasco V, Dinh-Xuan AT. Stereology: a bridge to a better understanding of lung structure and function. Eur Respir J 2010;35:477-8.
38. Ikeda H, Shiojima I, Oka T, et al. Increased Akt-mTOR signaling in lung epithelium is associated with respiratory distress syndrome in mice. Mol Cell Biol 2011;31:1054-65.
39. Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002;8:702-10.